Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis?

Paul Batty · 2026

Read Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis? by Paul Batty (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13478430.txt.

Description

Paul Batty reviewed in 2026 whether adeno-associated virus gene therapy risks insertional mutagenesis, where vector DNA lands in the genome and disrupts genes. Approved for several rare single-gene disorders, these vectors mostly persist as episomes outside chromosomes, with rare integration.

Wild-type virus integration appears in a small number of liver cancer cases, at most a minor risk factor, and structural differences limit translation to therapeutic vectors. Early mouse studies showed insertional mutagenesis, but findings were inconsistent and context-dependent, tied to high doses or neonatal treatment. No such reports exist in large animals or human biopsies. Long-term safety monitoring remains warranted.

Catalog record

CREATORPaul Batty
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13478430

Browse the full library · About the Tower of Babel